Enhancing Awareness of Diclofenac as an Over-the-Counter Analgesic in the Northern Border Region of Saudi Arabia
Seham Zaid Alshammari · Journal of Pharmaceutical Research International · 2023
Introduction: Diclofenac was identified by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency as a high-risk NSAID in terms of its effects on the heart and circulation when administered systemically, i.e. capsules, tablets or injections. Objective: T...
Open access
Research Article
10.9734/jpri/2023/v35i347480